by admin | Sep 19, 2022 | News & Opinions
by Brian Mattmiller In order to tap the tremendous potential of CRISPR gene editing technology for reversing human disease, Wisconsin scientists are working with a star pupil. The human eye — though one of the body’s most complex and intricate structures — happens to...
by admin | Sep 12, 2022 | News & Opinions
Moderna is suing Pfizer and BioNTech, alleging they copied technology that Moderna first developed years before the pandemic in producing the first COVID-19 vaccine approved in the U.S., the company announced Friday. Driving the news: Moderna is seeking unspecified...
by admin | Sep 11, 2022 | News & Opinions
By Sarah Collins and Jacqueline Garget – University of Cambridge Researchers from the University of Cambridge have created model embryos from mouse stem cells that form a brain, a beating heart, and the foundations of all the other organs of the body – a new...
by admin | Sep 6, 2022 | News & Opinions
Breaking News in #maculardegeneration! First time in USA! Commencement of a Phase 1/2a clinical safety trial using #IPSC stem cells to treat for advanced dry age-related macular degeneration. NIH and #JohnHopkins surgical team implanted a patch of tissue made from...
by admin | Jul 26, 2022 | News & Opinions
By Max Bayer – Fierce Biotech Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday...
